Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.

Authors :: Koutsilieris M
Dimopoulos T
Milathianakis C
Bogdanos J
Karamanolakis D
Pissimissis N
Halapas A
Lembessis P
Papaioannou A
Sourla A
Source :: BJU international [BJU Int] 2007 Jul; Vol. 100 Suppl 2, pp. 60-2.
Publication Year :: 2007

Subjects :: Bone Neoplasms secondary
Gonadotropin-Releasing Hormone antagonists & inhibitors
Humans
Male
Androgen Antagonists therapeutic use
Antineoplastic Agents, Hormonal therapeutic use
Bone Neoplasms drug therapy
Dexamethasone therapeutic use
Prostatic Neoplasms drug therapy
Somatostatin analogs & derivatives

Full Text Access

Tools